Company delivered ROE of 200.26% in year ending Mar 31, 2024 outperforming its 5 year avg. of -54.54%. (Source: Consolidated Financials)
Wanbury Share Price
Wanbury Share Price
Wanbury share price insights
Company has spent 5.07% of its operating revenues towards interest expenses and 15.1% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
Wanbury Ltd. share price moved up by 0.57% from its previous close of Rs 231.40. Wanbury Ltd. stock last traded price is 232.71
Share Price Value Today/Current/Last 232.71 Previous Day 231.40
Key Metrics
PE Ratio (x) | 14.57 | ||||||||||
EPS - TTM (₹) | 15.97 | ||||||||||
MCap (₹ Cr.) | 762.02 | ||||||||||
Sectoral MCap Rank | 80 | ||||||||||
PB Ratio (x) | 27.13 | ||||||||||
Div Yield (%) | 0.00 | ||||||||||
Face Value (₹) | 10.00 | ||||||||||
Beta Beta
| 0.60 | ||||||||||
VWAP (₹) | 235.71 | ||||||||||
52W H/L (₹) |
Wanbury Ltd Share Price Returns
1 Day | 0.57% |
1 Week | 11.25% |
1 Month | 7.79% |
3 Months | 51.8% |
1 Year | 347.52% |
3 Years | 180.54% |
5 Years | 1776.69% |
Wanbury News & Analysis
Wanbury Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
Wanbury Financials
Income (P&L)
Balance Sheet
Cash Flow
Ratios
Insights
Employee & Interest Expense
Company has spent 5.07% of its operating revenues towards interest expenses and 15.1% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
Quarterly | Annual Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Total Income 132.05 140.33 146.19 145.22 146.90 Total Income Growth (%) -5.90 -4.01 0.67 -1.15 12.21 Total Expenses 123.42 98.97 127.67 130.36 136.12 Total Expenses Growth (%) 24.71 -22.49 -2.06 -4.23 11.14 EBIT 8.63 41.37 18.52 14.86 10.78 EBIT Growth (%) -79.14 123.41 24.63 37.82 27.80 Profit after Tax (PAT) 1.04 33.63 10.27 7.36 4.69 PAT Growth (%) -96.92 227.40 39.54 57.03 361.58 EBIT Margin (%) 6.54 29.48 12.67 10.23 7.34 Net Profit Margin (%) 0.79 23.97 7.03 5.07 3.19 Basic EPS (₹) 0.32 10.28 3.13 2.25 1.43 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Total Assets 343.49 303.87 352.55 289.18 278.69 Total Assets Growth (%) 13.04 -13.81 21.91 3.76 -2.57 Total Liabilities 315.55 336.69 375.97 445.42 422.15 Total Liabilities Growth (%) -6.28 -10.45 -15.59 5.51 -14.77 Total Equity 27.94 -32.82 -23.42 -156.24 -143.45 Total Equity Growth (%) - - - - - Current Ratio (x) 0.74 0.39 0.48 0.28 0.30 Total Debt to Equity (x) 3.94 -1.95 -2.86 -0.57 -0.87 Contingent Liabilities 0.00 1,033.26 908.54 889.88 1,012.55 All figures in Rs Cr, unless mentioned otherwise
Insights
Increase in Cash from Investing
Company has used Rs 16.63 cr for investing activities which is an YoY increase of 88.12%. (Source: Consolidated Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Net Cash flow from Operating Activities 3.98 19.80 40.52 16.68 44.13 Net Cash used in Investing Activities -16.63 -8.84 0.59 8.04 63.66 Net Cash flow from Financing Activities 14.55 -31.99 -28.58 -17.39 -107.87 Net Cash Flow 1.91 -21.03 12.53 7.34 -0.08 Closing Cash & Cash Equivalent 3.40 1.49 22.53 10.00 2.66 Closing Cash & Cash Equivalent Growth (%) 127.54 -93.37 125.23 275.84 -2.88 Total Debt/ CFO (x) 27.64 3.24 1.65 5.30 2.82 All figures in Rs Cr, unless mentioned otherwise
Insights
ROE Outperforming 5 Year Average
Company delivered ROE of 200.26% in year ending Mar 31, 2024 outperforming its 5 year avg. of -54.54%. (Source: Consolidated Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Return on Equity (%) 200.26 0.00 -347.88 0.00 -44.93 Return on Capital Employed (%) 46.34 -70.89 -351.22 -16.12 -46.06 Return on Assets (%) 16.29 -3.42 23.10 -4.35 23.13 Interest Coverage Ratio (x) 2.50 1.13 1.79 0.89 0.75 Asset Turnover Ratio (x) 1.78 1.52 1.60 1.39 1.30 Price to Earnings (x) 8.54 -11.75 3.41 -16.47 0.71 Price to Book (x) 17.09 -3.72 -11.86 -1.33 -0.32 EV/EBITDA (x) 7.97 7.57 8.67 13.92 6.23 EBITDA Margin (%) 12.67 4.82 7.20 5.20 6.69
Wanbury Ltd Peer Comparison
Wanbury Ltd Stock Performance
Ratio Performance
Choose from Peers
Choose from Stocks
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...- See All Parameters
MF Ownership
MF Ownership details are not available.
Corporate Actions
Wanbury Board Meeting/AGM
Wanbury Dividends
- Others
Meeting Date Announced on Purpose Details Aug 12, 2024 Aug 06, 2024 Board Meeting Quarterly Results May 16, 2024 May 07, 2024 Board Meeting Audited Results Jan 24, 2024 Jan 12, 2024 Board Meeting Quarterly Results Nov 18, 2023 Oct 26, 2023 EGM - Oct 20, 2023 Oct 17, 2023 Board Meeting Quarterly Results & Preferential issue Type Dividend Dividend per Share Ex-Dividend Date Announced on Final 10% 1.0 Jul 29, 2010 May 31, 2010 Final 5% 0.5 Mar 12, 2009 Dec 31, 2008 Final 20% 2.0 Sep 13, 2007 Jun 29, 2007 Final 15% 1.5 Sep 07, 2006 Jun 28, 2006 Interim 5% 0.5 Feb 20, 2006 Jan 31, 2006 All Types Ex-Date Record Date Announced on Details Rights - - Sep 02, 1994 Rights ratio: 1 share for every 1 held at a price of Rs 10.0
About Wanbury
Wanbury Ltd., incorporated in the year 1988, is a Small Cap company (having a market cap of Rs 762.02 Crore) operating in Pharmaceuticals sector. Wanbury Ltd. key Products/Revenue Segments include Pharmaceuticals, Export Incentives and Scrap for the year ending 31-Mar-2023. Show More
Executives
Auditors
- KC
K Chandran
Vice Chairman & Whole Time DirKCK Chandran
Vice Chairman & Whole Time DirKCK Chandran
Vice Chairman & Whole Time DirNKN K Puri
Ind. Non-Executive DirectorShow More - V Parekh & Associates
Industry
Key Indices Listed on
-
Address
BSEL Tech Park, B-Wing,10th Floor, Sector 30-A,Opp. Vashi Railway Station,New Mumbai, Maharashtra - 400703
More Details
FAQs about Wanbury share
- 1. What's the Wanbury Ltd share price today?Wanbury Ltd share price was Rs 232.71 as on 29 Aug, 2024, 03:56 PM IST. Wanbury Ltd share price was up by 0.57% based on previous share price of Rs. 241.13.
- 2. What is the PE & PB ratio of Wanbury Ltd?The PE ratio of Wanbury Ltd stands at 14.49, while the PB ratio is 27.12.
- 3. What are the Wanbury Ltd quarterly results?Total Revenue and Earning for Wanbury Ltd for the year ending 2024-03-31 was Rs 578.64 Cr and Rs 55.96 Cr on Consolidated basis. Last Quarter 2024-06-30, Wanbury Ltd reported an income of Rs 132.05 Cr and profit of Rs 1.04 Cr.
- 4. How can I quickly analyze Wanbury Ltd stock?Key Metrics for Wanbury Ltd are:
- PE Ratio of Wanbury Ltd is 14.57
- Price/Sales ratio of Wanbury Ltd is 0.83
- Price to Book ratio of Wanbury Ltd is 27.13
- 5. What dividend is Wanbury Ltd giving?An equity Final dividend of Rs 1 per share was declared by Wanbury Ltd. on 31 May 2010. So, company has declared a dividend of 10% on face value of Rs 10 per share. The ex dividend date was 29 Jul 2010.
- 6. Who's the owner of Wanbury Ltd?
- Promoter holding have gone down from 39.8 (30 Sep 2023) to 39.79 (30 Jun 2024)
- Domestic Institutional Investors holding has not changed in last 9 months and holds 0.0 stake as on 30 Jun 2024
- Other investor holding have gone down from 60.2 (30 Sep 2023) to 59.99 (30 Jun 2024)
- 7. What are the returns for Wanbury Ltd share?Return Performance of Wanbury Ltd Shares:
- 1 Week: Wanbury Ltd share price moved up by 11.25%
- 3 Month: Wanbury Ltd share price moved up by 51.80%
- 6 Month: Wanbury Ltd share price moved up by 46.59%
- 8. What is 52 week high/low of Wanbury Ltd share price?In last 52 weeks Wanbury Ltd share had a high price of Rs 253.18 and low price of Rs 50.05
- 9. Who's the chairman of Wanbury Ltd?K Chandran is the Vice Chairman & Whole Time Dir of Wanbury Ltd
- 10. What is the market cap of Wanbury Ltd?Within the Pharmaceuticals sector, Wanbury Ltd stock has a market cap rank of 80. Wanbury Ltd has a market cap of Rs 762.02 Cr.
- 11. What is the CAGR of Wanbury Ltd?The CAGR of Wanbury Ltd is 10.05.
- 12. Who are the peers for Wanbury Ltd in Pharmaceuticals sector?Within Pharmaceuticals sector Wanbury Ltd, Zim Laboratories Ltd., Albert David Ltd., Kilitch Drugs(I) Ltd., Nectar Lifesciences Ltd., Medicamen Biotech Ltd., Venus Remedies Ltd., Lyka Labs Ltd., SMS Lifesciences India Ltd., Medico Remedies Ltd. and Ind-Swift Laboratories Ltd. are usually compared together by investors for analysis.
Trending in Markets
Wanbury Ltd Quick Links
Equity Quick Links
More from Markets
IPOStock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.